Alimta 500 mg (Pemetrexed)
|Product Name||: Alimta|
|Generic Name||: Pemetrexed|
|Available Pack Size||: 10’s|
|Available Strengths||: 500 mg|
|Registrations||: Export Only|
Request A Call Back
emetrexed is indicated for:
- Initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC) in combination with cisplatin.
- Maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy, as a single agent.
- Treatment of patients with recurrent, metastatic non-squamous, NSCLC after prior chemotherapy, as a single agent.